Australia markets open in 5 hours 9 minutes

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.76+0.19 (+3.50%)
As of 12:51PM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
973,730
1,598,951
1,146,290
475,598
18,662
Cost of revenue
370,557
902,639
-
-
-
Gross profit
603,173
696,312
-
-
-
Operating expenses
Research development
830,655
1,235,278
2,534,508
747,027
113,842
Selling general and administrative
475,372
488,691
298,358
145,290
34,417
Total operating expenses
1,229,995
1,341,048
2,832,866
892,317
148,259
Operating income or loss
-626,822
-644,736
-1,686,576
-416,719
-129,597
Interest expense
14,900
19,880
21,127
15,145
12,188
Total other income/expenses net
90,883
10,969
-8,197
12,591
9,003
Income before tax
-550,839
-653,647
-1,714,536
-418,259
-132,694
Income tax expense
-1,917
4,292
29,215
-
-
Income from continuing operations
-548,922
-657,939
-1,743,751
-418,259
-132,694
Net income
-548,922
-657,939
-1,743,751
-418,259
-132,694
Net income available to common shareholders
-548,922
-657,939
-1,743,751
-418,259
-132,694
Basic EPS
-7.14
-8.42
-23.44
-7.27
-5.51
Diluted EPS
-7.14
-8.42
-23.44
-7.27
-5.51
Basic average shares
83,415
78,183
74,400
57,554
24,100
Diluted average shares
83,415
78,183
74,400
57,554
24,100